Clinical study protocol for a low-interventional study in intermediate age-related macular degeneration developing novel clinical endpoints for interventional clinical trials with a regulatory and patient access intention-MACUSTAR

Trials. 2020 Jul 18;21(1):659. doi: 10.1186/s13063-020-04595-6.


Background: There is an unmet need for treatment options in intermediate age-related macular degeneration (iAMD). However, for any new interventions to be tested in clinical trials, novel currently unavailable clinical endpoints need to be developed. Thus, the MACUSTAR study aims to develop and evaluate functional, structural, and patient-reported candidate endpoints for use in future iAMD trials.

Methods: The protocol describes a low-interventional clinical multicenter study employing a novel two-part design. The cross-sectional part (total duration, 1 month) and the longitudinal part (total duration, 36 months) include participants with iAMD and control groups with early/late/no AMD. The cross-sectional part's primary objective is a technical evaluation of functional, structural, and patient-reported candidate outcomes. The longitudinal part's primary objective is to assess the prognostic power of changes in functional, structural, and patient-reported outcomes for progression from iAMD to late AMD. All data will be used to support a biomarker qualification procedure by regulatory authorities.

Discussion: The MACUSTAR study characterizes and evaluates much needed novel functional, structural, and patient-reported endpoints for future clinical trials in iAMD and will improve our understanding of the natural history and prognostic markers of this condition.

Trial registration: NCT03349801 . Registered on 22 November 2017.

Keywords: Clinical endpoint; Clinical study protocol; Disease progression; Intermediate age-related macular degeneration.

MeSH terms

  • Clinical Trials as Topic
  • Cross-Sectional Studies
  • Endpoint Determination*
  • Humans
  • Longitudinal Studies
  • Macular Degeneration* / diagnosis
  • Macular Degeneration* / therapy
  • Multicenter Studies as Topic
  • Observational Studies as Topic
  • Research Design*
  • Tomography, Optical Coherence

Associated data